DLH Holdings Corp

DLH Holdings Corp(DLHC)股票分析

$3.610

-0.020 (-0.55%)收盤時

Loading chart…
最高
3.690
開盤
3.545
成交量加權均價
3.62
成交量
3.78K
市值
152.43M
最低
3.545
成交金額
13.66K
企業價值/稅息折舊攤銷前利潤(TTM)
144.26

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.

AI 分析 of DLH Holdings Corp (DLHC)

買進

DLH Holdings Corp is a good buy right now, trading at $3.65, which is significantly below its 52-week high of $6.88. The stock has a low forward P/E ratio of 17.45, indicating potential undervaluation, especially given the recent positive news of securing a $250 million U.S. Navy contract. However, the company has reported a concerning net income loss of $16,787,000 in Q3 2026, which poses a risk to its financial stability.

分析師評級(2)

上檔空間 +177.01%
買進
2 買進
0 持有
0 賣出
目前: 3.61
最低
10.00
平均
10.00
最高
10.00

Noble Capital

2026-07-31

目標價

$7

優於大盤

Noble Capital

2025-05-09

目標價

$10

優於大盤

估值指標

DLH Holdings Corp(DLHC)目前預期本益比為 17.45,5 年平均預期本益比為 9.20。

預期本益比

合理
5 年均值 P/E
9.20
目前P/E
17.45
高估
34.86
低估
-16.46

預期 EV/EBITDA

嚴重高估
5 年均值 EV/EBITDA
15.86
目前EV/EBITDA
144.26
高估
48.31
低估
-16.58

預期股價營收比

合理
5 年均值 P/S
0.41
目前P/S
0.30
高估
0.55
低估
0.28

Alphio AI 對 DLHC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%DLHC

$5.55

情境價格

基

基準

基準 · 50%DLHC

$4.96

情境價格

悲

悲觀

悲觀 · 25%DLHC

$4.16

情境價格

事件時間軸

2026-10-05 (ET)

09:00:00

DLH Holdings Awarded NIH Data Governance Framework Task Order

2026-09-28 (ET)

09:00:00

DLH Holdings Awarded Task Order Worth Up to $19.1M from NIH

2026-09-16 (ET)

09:00:00

DLH Holdings Awarded Task Order Worth $43.7M

2026-06-30 (ET)

16:30:00

DLH Holdings Appoints Kathryn JohnBull as New CEO

2026-06-25 (ET)

16:30:00

DLH Holdings Awarded U.S. Navy Logistics IT Contract Worth $250M

資訊

DLHC 常見問題 —— 由 Alphio AI 解答

DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems. It operates in the Technology sector (SERVICES-HELP SUPPLY SERVICES industry).

DLH Holdings Corp is a good buy right now, trading at $3.65, which is significantly below its 52-week high of $6.88. The stock has a low forward P/E ratio of 17.45, indicating potential undervaluation, especially given the recent positive news of securing a $250 million U.S. Navy contract. However, the company has reported a concerning net income loss of $16,787,000 in Q3 2026, which poses a risk to its financial stability.

2 analysts cover DLHC: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易